• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Saturday, February 4, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Optical “tweezer” enables fast, low-cost screening of bacteria and cancer cells

Bioengineer by Bioengineer
December 23, 2022
in Cancer
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences (CAS) have proposed a new technology, called optical tweezer-assisted pool-screening and single-cell isolation (OPSI) system, which achieves 99.7% purity of sorting target cells, with all done in real-time.

Versatile, facile and low-cost single-cell isolation, culture and sequencing by optical tweezer-assisted pool-screening

Credit: LIU Yang

Researchers from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) of the Chinese Academy of Sciences (CAS) have proposed a new technology, called optical tweezer-assisted pool-screening and single-cell isolation (OPSI) system, which achieves 99.7% purity of sorting target cells, with all done in real-time.

The study was published in Lab on a Chip on Nov. 29.

Current cell-sorting methods cannot effectively sort cells of various sizes while maintaining their viability for future testing. Compared with the currently used methods, the OPSI technology reduces cost and resources consumed. It also saves time, which is of utmost importance when dealing with abnormal cells or pathogens. 

Imagine a regular pair of tweezers: they’re used for grabbing small, often unwanted, objects such as a stray hair or splinter. An optical tweezer utilizes this same idea, but instead of a metal object, it is a highly focused laser that can hold, manipulate, and move the desired object, which in this case are the target cells. 

Being able to pick or “tweeze” out certain cells comes in handy when dealing with cancerous or other target cells and pathogens that need to be further studied. This optical tweezer is utilized on a cell pool confined in a microfluidics chip, which is usually a glass slide with microchannels molded into the material. Once the target cell is identified (usually through targeted fluorescence, Raman imaging or bright-field microscopy), it can easily be packaged in a microdroplet and exported in a “one-cell one-tube” manner for later amplification and analysis. 

“Real-time image-based sorting of target cells in a precisely indexed manner is desirable for sequencing or cultivating individual human or microbial cells directly from clinical or environmental samples, however, versatility of existing methods is limited as they are usually not broadly applicable to all cell sizes,” said XU Teng, paper-first author from Single-Cell Center of QIBEBT. 

An artificial test mixture of green-fluorescent protein (GFP) E. coli, non-GFP E. coli and yeast were loaded onto the chip in a 1:1:1 ratio, and quickly the GFP bacteria and yeast were separated. 

To further test the efficacy of this method, a mixture using only 0.1% of the GFP E. coli was used, and the fluorescent cells were easily detected and isolated amidst a mixture of other cells of varying sizes.

“The precise isolation and broad spectrum of cell sizes that can be manipulated using OPSI not only allows for easy target cell acquisition but can also greatly reduce the volume required to study the sample,” said co-first author LI Yuandong, an engineer at Single-Cell Center of QIBEBT. Isolating and capturing the target cells in microdroplets also maintains a high quality of the cell’s information, allowing for more genes to be detected while minimizing the resources needed. “This is of particular importance when it comes to rare or small samples which can easily be consumed entirely in one test which may not even maintain the quality of the sample.” 

“Taking advantage of the wide-field imaging rather than detecting single cells one by one in flowing stream, the recognition of target cell can be very fast,” said co-corresponding author Prof. XU Jian, from Single-Cell Center of QIBEBT. “OPSI also achieves >99.7% target-cell sorting purity and 10-fold elevated speed of 10~20 cells/min.” 

In the next step, introduction of artificial intelligence-based automatic recognition to this OPSI chip method, along with automatic manipulation steps, may further increase the throughput and greatly broaden the usage of this technology, according to Prof. MA Bo from Single-Cell Center of QIBEBT, who led the study.



Journal

Lab on a Chip

DOI

10.1039/D2LC00888B

Article Title

Versatile, facile and low-cost single-cell isolation, culture and sequencing by optical tweezer-assisted pool-screening

Article Publication Date

29-Nov-2022

Share12Tweet8Share2ShareShareShare2

Related Posts

Brooke Emerling, Ph.D.

New treatment approach for prostate cancer could stop resistance in its tracks

February 3, 2023
MOU signing

MD Anderson announces new collaboration in Indonesia to reduce global cancer burden

February 3, 2023

Genes & Cancer | Leveraging allogeneic dendritic cells for neoantigen cancer vaccines

February 3, 2023

HKUMed discovers a new tumour suppressive gene which boosts personalised treatment response in breast cancer

February 3, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Preference for naturally talented over hard workers emerges in childhood, HKUST researchers find

Black South Africans report higher life satisfaction and are at less risk for depression post-migration, MU study finds

New treatment approach for prostate cancer could stop resistance in its tracks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In